COP
54
3
KSS
33
-6
XYL
58
6
XEL
62
-3
C
62
9
USB
47
4
PYPL
47
2
EOG
50
3
TEL
66
3
BAX
33
-2
MDT
55
3
CLX
63
7
VRSK
38
3
ZTS
58
-5
GD
59
2
NTRS
54
7
VLO
45
3
ADI
61
5
FTI
78
9
EXC
47
-3
COP
54
3
KSS
33
-6
XYL
58
6
XEL
62
-3
C
62
9
USB
47
4
PYPL
47
2
EOG
50
3
TEL
66
3
BAX
33
-2
MDT
55
3
CLX
63
7
VRSK
38
3
ZTS
58
-5
GD
59
2
NTRS
54
7
VLO
45
3
ADI
61
5
FTI
78
9
EXC
47
-3
Financhill
Back

Eton Pharmaceuticals 10K Form

Buy
68

ETON
Eton Pharmaceuticals

Last Price:
5.89
Seasonality Move:
3.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ETON News And Ratings

See the #1 stock for the next 7 days that we like better than ETON

ETON Financial Statistics

Sales & Book Value

Annual Sales: $31.64M
Cash Flow: $1.26M
Price / Cash Flow: 0
Annual Sales: $0.52
Price / Book: 11.32

Profitability

EPS (TTM): -0.26000
Net Income (TTM): $-6.69M
Gross Margin: $21.06M
Return on Equity: -42.84%
Return on Assets: -21.32%

Eton Pharmaceuticals Earnings Forecast

Key Eton Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for ETON is 66.56%.
  • The Selling, General & Administrative Expenses for ETON have been equal to 59.83% of Gross Profit Margin.
  • The Research & Development expenses have been 10.50% of Revenue.
  • The Net Earning history of ETON is -2.96% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Eton Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ETON
CUSIP: 29772L
Website: etonpharma.com

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 1.4
Quick Ratio: 1.24

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 22.26

ETON Technical Analysis vs Fundamental Analysis

Buy
68
Eton Pharmaceuticals (ETON) is a Buy

Is Eton Pharmaceuticals a Buy or a Sell?